Reply to the letter to the editor 'A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma' by Rosati et al.

[1]  L. Wyrwicz,et al.  Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  L. Wood,et al.  Extranodal extension is an important prognostic parameter for both colonic and rectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Q. Huang,et al.  Prognostic impact of extracapsular lymph node involvement in colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  V. Catalano,et al.  Number needed to treat for pricing costly anticancer drugs: the example of regorafenib in metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  S. Barni,et al.  A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  A. Lo,et al.  Price, value, and the cost of cancer drugs. , 2016, The Lancet. Oncology.

[7]  L. Wood,et al.  Prognostic impact and implications of extracapsular lymph node involvement in colorectal cancer: a systematic review with meta-analysis. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  Ortwin Renn,et al.  Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions , 2015, Clinical pharmacology and therapeutics.

[9]  E. D. de Vries,et al.  Rectal and colon cancer: Not just a different anatomic site. , 2015, Cancer treatment reviews.

[10]  R. Perera,et al.  Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. , 2013, JAMA.

[11]  R. Labianca,et al.  Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.